Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Glyoxalase in tumourigenesis and multidrug resistance.

Thornalley PJ, Rabbani N.

Semin Cell Dev Biol. 2011 May;22(3):318-25. doi: 10.1016/j.semcdb.2011.02.006. Epub 2011 Feb 18. Review.

PMID:
21315826
3.

Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance.

Thornalley PJ, Waris S, Fleming T, Santarius T, Larkin SJ, Winklhofer-Roob BM, Stratton MR, Rabbani N.

Nucleic Acids Res. 2010 Sep;38(16):5432-42. doi: 10.1093/nar/gkq306. Epub 2010 Apr 30.

4.

Glyoxalase I in tumor cell proliferation and survival and as a potential target for anticancer therapy.

Geng X, Ma J, Zhang F, Xu C.

Oncol Res Treat. 2014;37(10):570-4. doi: 10.1159/000367800. Epub 2014 Sep 11. Review.

PMID:
25342507
5.

Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments.

Rabbani N, Xue M, Thornalley PJ.

Clin Sci (Lond). 2016 Oct 1;130(19):1677-96. doi: 10.1042/CS20160025. Review.

PMID:
27555612
6.

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, Haga N.

Cancer Sci. 2003 Jan;94(1):15-21. Review.

7.

Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy.

Rabbani N, Xue M, Weickert MO, Thornalley PJ.

Semin Cancer Biol. 2017 May 12. pii: S1044-579X(17)30035-4. doi: 10.1016/j.semcancer.2017.05.006. [Epub ahead of print] Review.

PMID:
28506645
8.

The glyoxalase system--from microbial metabolism, through ageing to human disease and multidrug resistance.

Rabbani N, Thornalley PJ.

Semin Cell Dev Biol. 2011 May;22(3):261. doi: 10.1016/j.semcdb.2011.02.014. Epub 2011 Feb 18. No abstract available.

PMID:
21316480
9.

Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line.

Ranganathan S, Walsh ES, Tew KD.

Biochem J. 1995 Jul 1;309 ( Pt 1):127-31.

10.

Role of the glyoxalase system in astrocyte-mediated neuroprotection.

BĂ©langer M, Yang J, Petit JM, Laroche T, Magistretti PJ, Allaman I.

J Neurosci. 2011 Dec 14;31(50):18338-52. doi: 10.1523/JNEUROSCI.1249-11.2011.

11.

Glyoxalase in diabetes, obesity and related disorders.

Rabbani N, Thornalley PJ.

Semin Cell Dev Biol. 2011 May;22(3):309-17. doi: 10.1016/j.semcdb.2011.02.015. Epub 2011 Feb 16. Review.

PMID:
21335095
12.

Activity, regulation, copy number and function in the glyoxalase system.

Rabbani N, Xue M, Thornalley PJ.

Biochem Soc Trans. 2014 Apr;42(2):419-24. doi: 10.1042/BST20140008. Review.

PMID:
24646254
13.

Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules.

Taniguchi H, Horinaka M, Yoshida T, Yano K, Goda AE, Yasuda S, Wakada M, Sakai T.

Mol Cancer Ther. 2012 Oct;11(10):2294-300. doi: 10.1158/1535-7163.MCT-12-0031. Epub 2012 Jul 11.

14.

Copy number variation of glyoxalase I.

Shafie A, Xue M, Thornalley PJ, Rabbani N.

Biochem Soc Trans. 2014 Apr;42(2):500-3. doi: 10.1042/BST20140011. Review.

PMID:
24646268
15.

Modulation of GLO1 Expression Affects Malignant Properties of Cells.

Hutschenreuther A, Bigl M, Hemdan NY, Debebe T, Gaunitz F, Birkenmeier G.

Int J Mol Sci. 2016 Dec 18;17(12). pii: E2133. doi: 10.3390/ijms17122133.

16.

The glyoxalase pathway: the first hundred years... and beyond.

Sousa Silva M, Gomes RA, Ferreira AE, Ponces Freire A, Cordeiro C.

Biochem J. 2013 Jul 1;453(1):1-15. doi: 10.1042/BJ20121743. Review.

PMID:
23763312
17.

Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?

Merk J, Rolff J, Dorn C, Leschber G, Fichtner I.

Eur J Cardiothorac Surg. 2011 Jul;40(1):e29-33. doi: 10.1016/j.ejcts.2011.02.010. Epub 2011 Mar 21.

PMID:
21420313
18.

Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation.

Thornalley PJ.

Biochem Soc Trans. 2003 Dec;31(Pt 6):1343-8. Review.

PMID:
14641060
19.

Glyoxalase Centennial conference: introduction, history of research on the glyoxalase system and future prospects.

Rabbani N, Thornalley PJ.

Biochem Soc Trans. 2014 Apr;42(2):413-8. doi: 10.1042/BST20140014.

PMID:
24646253
20.

Glyoxalase I inhibitors in cancer chemotherapy.

Creighton DJ, Zheng ZB, Holewinski R, Hamilton DS, Eiseman JL.

Biochem Soc Trans. 2003 Dec;31(Pt 6):1378-82. Review.

PMID:
14641067

Supplemental Content

Support Center